SCHEMBL12349852

SCHEMBL12349852

CCN(CC)CCn1nc2c3c(cccc3c1=O)-c1ccccc1-2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ HTT P42858 2/20 1.00
▸ L3MBTL1 Q9Y468 2/20 1.00
▸ NPC1 O15118 1/20 1.00
▸ MITF O75030 1/20 1.00
▸ DNMT1 P26358 1/20 1.00
▸ RAD52 P43351 1/20 1.00
▸ RAB9A P51151 1/20 1.00
▸ SMN1; SMN2 Q16637 1/20 1.00
▸ UHRF1 Q96T88 1/20 1.00
▸ ALDH1A1 P00352 4/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ LMNA P02545 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ ATG4B Q9Y4P1 1/20 0.43
▸ KAT2B Q92831 1/20 0.43
▸ TOP2A P11388 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567461 1.00 POLB (1.00) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL15440804 0.80 HTT (0.67) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL13467765 0.79 POLB (0.65) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL15440670 0.75 POLB (0.60) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL12349851 0.75 ALDH1A1 (0.65) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL15440705 0.73 POLB (0.57) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL10799708 0.71 POLB (0.55) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL7496921 0.70 POLB (0.54) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL12349886 0.70 POLB (0.54) POLBKMT2AHTTL3MBTL1NPC1
SCHEMBL10502880 0.69 POLB (0.53) POLBKMT2AHTTL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120308608-A1 INTERFERON-INDUCING COMPOUNDS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-12-06 — — US disclosed
US-20120308608-A1 INTERFERON-INDUCING COMPOUNDS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-12-06 — — US disclosed
WO-2011094693-A1 INTERFERON-INDUCING COMPOUNDS AND USES THEREOF MOUNT SINAI SCHOOL OF MEDICINE (US) 2011-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120308608-A1 INTERFERON-INDUCING COMPOUNDS AND USES THEREOF IRF3, IFNG, IFNAR1 POLB 927/4885KMT2A 4305/4885HTT 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback